Pharmacological modulation of ApoA- and ApoB-containing lipoproteins.
Bard
J M
JM
SERLIA et Inserm U325, Institut Pasteur de Lille, France.
D001054:Apolipoproteins A / Q000032:analysis / Q000187:drug effects*; D001055:Apolipoproteins B / Q000097:blood / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000097:blood; D005260:Female; D006801:Humans; D007158:Immunologic Techniques; D008074:Lipoproteins / Q000145:classification; D008297:Male
D001054:Apolipoproteins A; D001055:Apolipoproteins B; D008074:Lipoproteins